In vivo investigation of hyperpolarized [1,3-13C2]acetoacetate as a metabolic probe in normal brain and in glioma
Open Access
- 4 March 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 3402
Abstract
Dysregulation in NAD+/NADH levels is associated with increased cell division and elevated levels of reactive oxygen species in rapidly proliferating cancer cells. Conversion of the ketone body acetoacetate (AcAc) to β-hydroxybutyrate (β-HB) by the mitochondrial enzyme β-hydroxybutyrate dehydrogenase (BDH) depends upon NADH availability. The β-HB-to-AcAc ratio is therefore expected to reflect mitochondrial redox. Previous studies reported the potential of hyperpolarized 13C-AcAc to monitor mitochondrial redox in cells, perfused organs and in vivo. However, the ability of hyperpolarized 13C-AcAc to cross the blood brain barrier (BBB) and its potential to monitor brain metabolism remained unknown. Our goal was to assess the value of hyperpolarized [1,3-13C2]AcAc in healthy and tumor-bearing mice in vivo. Following hyperpolarized [1,3-13C2]AcAc injection, production of [1,3-13C2]β-HB was detected in normal and tumor-bearing mice. Significantly higher levels of [1-13C]AcAc and lower [1-13C]β-HB-to-[1-13C]AcAc ratios were observed in tumor-bearing mice. These results were consistent with decreased BDH activity in tumors and associated with increased total cellular NAD+/NADH. Our study confirmed that AcAc crosses the BBB and can be used for monitoring metabolism in the brain. It highlights the potential of AcAc for future clinical translation and its potential utility for monitoring metabolic changes associated with glioma, and other neurological disorders.Keywords
Funding Information
- American Brain Tumor Association (BRF1700006)
- National Cancer Institute (R01CA1972254, R01CA172845, R01CA1972254, R01CA172845, R01CA1972254, R01CA172845, R01CA1972254, R01CA172845, R01CA1972254, R01CA172845, R01CA1972254, R01CA172845, R01CA1972254, R01CA172845, R01CA1972254, R01CA172845)
- NIH Hyperpolarized MRI Technology Resource Center UCSF NICO Project UCSF Brain Tumor Center Loglio Collective
This publication has 53 references indexed in Scilit:
- Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapyNutrition & Metabolism, 2013
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypeNature, 2012
- The monocarboxylate transporter family—Structure and functional characterizationIUBMB Life, 2011
- Hyperpolarized 13 C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imagingProceedings of the National Academy of Sciences, 2011
- Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapyBMC Cancer, 2011
- Clinical review: Ketones and brain injuryCritical Care, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRIBritish Journal of Cancer, 2008
- Evidence for the existence of enzymatic variants of β-hydroxybutyrate dehydrogenase from rat liver and brain mitochondriaLife Sciences, 1977
- THE MITOCHONDRIAL REDOX STATE OF RAT BRAINJournal of Neurochemistry, 1973